• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

干扰素-α介导黑素瘤细胞上HLA I类分子的上调,而不会将蛋白酶体转换为免疫蛋白酶体。

IFN-alpha mediates the up-regulation of HLA class I on melanoma cells without switching proteasome to immunoproteasome.

作者信息

Cangemi Giuliana, Morandi Barbara, D'Agostino Antonella, Peri Cristiano, Conte Romana, Damonte Gianluca, Ferlazzo Guido, Biassoni Roberto, Melioli Giovanni

机构信息

Laboratorio di Analisi, Istituto Giannina Gaslini, 16148 Genoa, Italy.

出版信息

Int Immunol. 2003 Dec;15(12):1415-21. doi: 10.1093/intimm/dxg140.

DOI:10.1093/intimm/dxg140
PMID:14645150
Abstract

Treatment of melanoma cell lines with IFN-gamma induces the switch from proteasome (PS) to immunoproteasome (iPS). This finding has profound implications for the immunobiology of melanoma cells since certain peptides (such as Melan-A(mart1)(27-35)) are cleaved differently by iPS, thus implying a different ability to be presented by HLA class I molecules. IFN-alpha is a cytokine not only produced during infectious diseases, but also used in the treatment of certain cancers. Nevertheless, the effects of IFN-alpha on the switch of PS to iPS are largely unknown. A comparison of the effect of both IFN-alpha and IFN-gamma was thus carried out on melanoma cell lines. RT-PCR showed that mRNA for iPS subunits (i.e. LMP-2, LMP-7 and MECL-1) was detectable both in untreated and IFN-treated melanoma cells. Immunoblotting analysis revealed that while IFN-gamma was able to consistently induce the switch from PS to iPS, IFN-alpha treatment did not, possibly due to post-transcriptional event(s) blocking the expression of iPS-specific subunits. Finally, Melan-A(mart1)(27-35) peptide was found only in the HPLC-MS spectra from both untreated and IFN-alpha-treated cells, but not upon IFN-gamma treatment. Altogether, these data demonstrate that IFN-alpha does not induce the switch from PS to iPS.

摘要

用γ干扰素处理黑色素瘤细胞系可诱导其从蛋白酶体(PS)转变为免疫蛋白酶体(iPS)。这一发现对黑色素瘤细胞的免疫生物学具有深远意义,因为某些肽段(如黑色素瘤抗原A(mart1)(27 - 35))被iPS切割的方式不同,这意味着其由I类人白细胞抗原分子呈递的能力也不同。α干扰素不仅是在感染性疾病期间产生的一种细胞因子,也被用于某些癌症的治疗。然而,α干扰素对PS向iPS转变的影响在很大程度上尚不清楚。因此,对黑色素瘤细胞系进行了α干扰素和γ干扰素作用效果的比较。逆转录 - 聚合酶链反应显示,在未处理和经干扰素处理的黑色素瘤细胞中均能检测到iPS亚基(即低分子量多肽2(LMP - 2)、低分子量多肽7(LMP - 7)和MECL - 1)的信使核糖核酸。免疫印迹分析表明,虽然γ干扰素能够持续诱导从PS到iPS的转变,但α干扰素处理却不能,这可能是由于转录后事件阻断了iPS特异性亚基的表达。最后,仅在未处理和经α干扰素处理的细胞的高效液相色谱 - 质谱图谱中发现了黑色素瘤抗原A(mart1)(27 - 35)肽段,而在经γ干扰素处理的细胞中未发现。总之,这些数据表明α干扰素不会诱导从PS到iPS的转变。

相似文献

1
IFN-alpha mediates the up-regulation of HLA class I on melanoma cells without switching proteasome to immunoproteasome.干扰素-α介导黑素瘤细胞上HLA I类分子的上调,而不会将蛋白酶体转换为免疫蛋白酶体。
Int Immunol. 2003 Dec;15(12):1415-21. doi: 10.1093/intimm/dxg140.
2
Impaired expression of proteasome subunits and human leukocyte antigens class I in human colon cancer cells.人结肠癌细胞中蛋白酶体亚基和人类白细胞抗原I类的表达受损。
J Gastroenterol Hepatol. 2003 Jan;18(1):32-40. doi: 10.1046/j.1440-1746.2003.02921.x.
3
High frequency of functionally active Melan-a-specific T cells in a patient with progressive immunoproteasome-deficient melanoma.一名进行性免疫蛋白酶体缺陷型黑色素瘤患者体内功能活跃的黑色素-a特异性T细胞频率较高。
Cancer Res. 2004 Sep 1;64(17):6319-26. doi: 10.1158/0008-5472.CAN-04-1341.
4
Proteasome activity limits the assembly of MHC class I molecules after IFN-gamma stimulation.蛋白酶体活性限制了γ干扰素刺激后MHC I类分子的组装。
J Immunol. 1997 Dec 15;159(12):5896-904.
5
Antigen presentation by MHC class I and its regulation by interferon gamma.MHC I类分子介导的抗原呈递及其受干扰素γ的调控
Curr Opin Immunol. 1999 Feb;11(1):76-81. doi: 10.1016/s0952-7915(99)80014-4.
6
Interferon-gamma differentially regulates susceptibility of lung cancer cells to telomerase-specific cytotoxic T lymphocytes.干扰素-γ差异性地调节肺癌细胞对端粒酶特异性细胞毒性T淋巴细胞的敏感性。
Int J Cancer. 2004 Jun 20;110(3):403-12. doi: 10.1002/ijc.20139.
7
alpha-Interferon treatment induces quantitative modifications of HLA class I-associated peptides eluted from cultured cancer cell lines.α-干扰素治疗可诱导从培养的癌细胞系中洗脱的HLA I类相关肽发生定量改变。
Tissue Antigens. 2000 Mar;55(3):212-8. doi: 10.1034/j.1399-0039.2000.550304.x.
8
Histone deacetylase inhibitors induce TAP, LMP, Tapasin genes and MHC class I antigen presentation by melanoma cells.组蛋白去乙酰化酶抑制剂可诱导黑色素瘤细胞表达TAP、LMP、Tapasin基因并促进MHC I类抗原呈递。
Cancer Immunol Immunother. 2008 May;57(5):647-54. doi: 10.1007/s00262-007-0402-4. Epub 2007 Nov 28.
9
Development and characterization of human constitutive proteasome and immunoproteasome subunit-specific monoclonal antibodies.人组成型蛋白酶体和免疫蛋白酶体亚基特异性单克隆抗体的开发与特性分析
Tissue Antigens. 2005 Sep;66(3):185-94. doi: 10.1111/j.1399-0039.2005.00462.x.
10
Tumor escape from immune recognition: loss of HLA-A2 melanoma cell surface expression is associated with a complex rearrangement of the short arm of chromosome 6.肿瘤逃避免疫识别:HLA - A2黑色素瘤细胞表面表达缺失与6号染色体短臂的复杂重排相关。
Clin Cancer Res. 1996 Apr;2(4):641-52.

引用本文的文献

1
HLA-E and HLA-F Are Overexpressed in Glioblastoma and HLA-E Increased After Exposure to Ionizing Radiation.HLA-E 和 HLA-F 在胶质母细胞瘤中过表达,并且在暴露于电离辐射后 HLA-E 增加。
Cancer Genomics Proteomics. 2022 Mar-Apr;19(2):151-162. doi: 10.21873/cgp.20311.
2
Tackling HLA Deficiencies Head on with Oncolytic Viruses.用溶瘤病毒直接攻克HLA缺陷
Cancers (Basel). 2021 Feb 10;13(4):719. doi: 10.3390/cancers13040719.
3
Combination immunotherapies implementing adoptive T-cell transfer for advanced-stage melanoma.采用过继性T细胞转移治疗晚期黑色素瘤的联合免疫疗法。
Melanoma Res. 2018 Jun;28(3):171-184. doi: 10.1097/CMR.0000000000000436.
4
Biological insights into BRAF mutations in melanoma patient: Not mere therapeutic targets.黑色素瘤患者BRAF突变的生物学见解:不仅仅是治疗靶点。
Oncoimmunology. 2013 Aug 1;2(8):e25594. doi: 10.4161/onci.25594. Epub 2013 Jul 3.
5
Successful treatment of metastatic melanoma by adoptive transfer of blood-derived polyclonal tumor-specific CD4+ and CD8+ T cells in combination with low-dose interferon-alpha.采用低剂量干扰素-α联合血液来源的多克隆肿瘤特异性 CD4+和 CD8+T 细胞过继转移治疗转移性黑色素瘤。
Cancer Immunol Immunother. 2011 Jul;60(7):953-63. doi: 10.1007/s00262-011-1004-8. Epub 2011 Mar 24.
6
Immunotherapy for melanoma: current status and perspectives.黑色素瘤的免疫治疗:现状与展望。
J Immunother. 2010 Jul-Aug;33(6):570-90. doi: 10.1097/CJI.0b013e3181e032e8.
7
Virus-induced type I IFN stimulates generation of immunoproteasomes at the site of infection.病毒诱导的I型干扰素刺激感染部位免疫蛋白酶体的生成。
J Clin Invest. 2006 Nov;116(11):3006-14. doi: 10.1172/JCI29832. Epub 2006 Oct 12.